The new plant will give Novartis end-to-end capabilities centered on North Carolina, where it plans to have five facilities ...
Novartis has finalized its $23 billion U.S. manufacturing and R&D expansion with plans for a new active pharmaceutical ingredient facility in Morrisville, North Carolina. The 56,200-square-foot site ...
Novartis will construct an active pharmaceutical ingredient (API) facility in Morrisville, North Carolina, the company said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results